These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7975491)

  • 1. Kill and cure. The hope and reality of virus inactivation.
    Prowse C
    Vox Sang; 1994; 67 Suppl 3():191-6. PubMed ID: 7975491
    [No Abstract]   [Full Text] [Related]  

  • 2. Virus inactivation of fresh plasma.
    Mohr H
    Vox Sang; 1998; 74 Suppl 2():171-2. PubMed ID: 9704442
    [No Abstract]   [Full Text] [Related]  

  • 3. [Virus in hemophilia: current status and future perspectives].
    Aguilar C; Félix Lucía J
    Sangre (Barc); 1996 Apr; 41(2):141-5. PubMed ID: 9045355
    [No Abstract]   [Full Text] [Related]  

  • 4. Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma.
    Wagner SJ; Friedman LI; Dodd RY
    Transfus Med Rev; 1991 Jan; 5(1):18-32. PubMed ID: 1802274
    [No Abstract]   [Full Text] [Related]  

  • 5. Photodynamic virus inactivation of blood components.
    Mohr H; Lambrecht B; Selz A
    Immunol Invest; 1995; 24(1-2):73-85. PubMed ID: 7713607
    [No Abstract]   [Full Text] [Related]  

  • 6. [Viral safety considerations in immunoglobulin preparations].
    Gómez Manzano P; Escrivá CA; Salmerón García F; Alonso Verduras C
    Sangre (Barc); 1997 Jun; 42(3):199-203. PubMed ID: 9381262
    [No Abstract]   [Full Text] [Related]  

  • 7. Inactivation of viruses in blood and plasma products.
    Suomela H
    Transfus Med Rev; 1993 Jan; 7(1):42-57. PubMed ID: 8431658
    [No Abstract]   [Full Text] [Related]  

  • 8. Reducing the residual risk of transfusion-transmitted viruses: mini-pool or single-donation NAT?
    Roth WK; Seifried E
    Transfusion; 2001 Jun; 41(6):845-7. PubMed ID: 11399831
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
    Ristol P; Gensana M; Fernández J; Massot M; Biescas H; Darling A; Jorquera JI; Vericat F
    Sangre (Barc); 1996 Apr; 41(2):131-6. PubMed ID: 9045353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful clinical use of a plasma-derived, dual virus inactivated factor VII concentrate incorporating solvent-detergent and dry heat treatment.
    Smith MP; Rice KM; Savidge GF
    Thromb Haemost; 1997 Feb; 77(2):406-7. PubMed ID: 9157608
    [No Abstract]   [Full Text] [Related]  

  • 11. [Viral safety measures of plasma for transfusion and applicability in Spain].
    Pereira A
    Med Clin (Barc); 2007 Oct; 129(12):458-68. PubMed ID: 17953912
    [No Abstract]   [Full Text] [Related]  

  • 12. Genomic screening for blood-borne viruses in transfusion settings.
    Lee HH; Allain JP
    Vox Sang; 1998; 74 Suppl 2():119-23. PubMed ID: 9704433
    [No Abstract]   [Full Text] [Related]  

  • 13. Strategies for reducing the exposure to donor blood.
    Murphy M
    Clin Med (Lond); 2005; 5(4):337-40. PubMed ID: 16138487
    [No Abstract]   [Full Text] [Related]  

  • 14. Inactivation of viruses found with plasma proteins.
    Horowitz B
    Biotechnology; 1991; 19():417-30. PubMed ID: 1786476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus inactivation in blood components by photoactive phenothiazine dyes.
    Wagner SJ
    Transfus Med Rev; 2002 Jan; 16(1):61-6. PubMed ID: 11788930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus validation experiments on the production process of OCTAVI SDPlus.
    Biesert L; Lemon S; Suhartono H; Wang L; Rübsamen H
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S48-54. PubMed ID: 7495968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A solvent I detergent treated, pasteurised and highly purified factor VIII concentrate.
    Schwinn H; Stadler M; Josic D; Bal F; Gehringer W; Nur I; Schütz R
    Arzneimittelforschung; 1994 Feb; 44(2):188-91. PubMed ID: 8147954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoinactivation of viruses and cells for medical applications.
    Corash L; Hanson CV
    Blood Cells; 1992; 18(1):3-5. PubMed ID: 1617191
    [No Abstract]   [Full Text] [Related]  

  • 19. [Viral safety of hemoderivatives: in search of zero risk].
    Hernández JM; Tusell JM
    Sangre (Barc); 1996 Apr; 41(2):97-100. PubMed ID: 9045365
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of leukodepletion in the control of transfusion-transmitted disease.
    Goldman M; Delage G
    Transfus Med Rev; 1995 Jan; 9(1):9-19. PubMed ID: 7719040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.